Why the study?
Does laparoscopic Roux-en-Y gastric bypass improve weight loss and metabolic control compared to sleeve gastrectomy in patients with and without T2DM?
Does laparoscopic Roux-en-Y gastric bypass improve weight loss and metabolic control compared to sleeve gastrectomy in patients with and without T2DM?
Laparoscopic Roux-en-Y gastric bypass is more effective than sleeve gastrectomy for weight loss and metabolic control, suggesting it should be the preferred option for patients with obesity and T2DM or dyslipidemia.
Answers are grounded in this paper and cite their sources.
RYGB should be preferred over SG for weight loss and metabolic control in obesity with T2DM; confirms superiority in short- and mid-term outcomes.
Based on this meta-analysis, RYGB is more effective than SG in improving weight loss and short- and mid-term glycaemic and lipid metabolism control in patients with and without T2DM. Therefore, unless contraindicated, RYGB should be the first choice to treat patients with obesity and T2DM and/or dyslipidaemia.
No takes yet. Share an insight, caveat, or question.
Hayoz et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: